150 related articles for article (PubMed ID: 31432632)
21. CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease.
Carbone A; Gloghini A; Gruss HJ; Pinto A
Am J Pathol; 1995 Oct; 147(4):912-22. PubMed ID: 7573367
[TBL] [Abstract][Full Text] [Related]
22. p27(Kip1) immunostaining for the differential diagnosis of small b-cell neoplasms in trephine bone marrow biopsies.
Kremer M; Dirnhofer S; Nickl A; Hoefler H; Quintanilla-Martínez L; Fend F
Mod Pathol; 2001 Oct; 14(10):1022-9. PubMed ID: 11598173
[TBL] [Abstract][Full Text] [Related]
23. Sinonasal lymphoma: a clinicopathologic analysis of 58 cases from the Massachusetts General Hospital.
Cuadra-Garcia I; Proulx GM; Wu CL; Wang CC; Pilch BZ; Harris NL; Ferry JA
Am J Surg Pathol; 1999 Nov; 23(11):1356-69. PubMed ID: 10555004
[TBL] [Abstract][Full Text] [Related]
24. Bone marrow and peripheral blood natural killer cell activity in lymphomas. Its response to IL-2.
Caldera LH; Leon-Ponte M; Acquatella G; Bianco NE; Blanca I
Clin Exp Immunol; 1992 Apr; 88(1):143-8. PubMed ID: 1373350
[TBL] [Abstract][Full Text] [Related]
25. Immunotherapeutic potential of JL1, a thymocyte surface protein, for leukemia.
Kim TJ; Park SH
J Korean Med Sci; 1998 Oct; 13(5):455-8. PubMed ID: 9811172
[TBL] [Abstract][Full Text] [Related]
26. Bone marrow trephine biopsy involvement by lymphoma: pattern of involvement and concordance with flow cytometry, in 10 years from a single institution.
Cabezas-Quintario MA; Gomez P; Yuste-Del Pozo V; Valencia-Mesa AL; Sosa G; Ricard P; Hijas-Gómez AI; Pinedo F; Arguelles M
Clin Transl Oncol; 2016 May; 18(5):537-40. PubMed ID: 26311078
[TBL] [Abstract][Full Text] [Related]
27. Impaired T and NK cell response of bone marrow and peripheral blood stem cell products to interleukin (IL)-2.
Ozerol I; Ageitos A; Heimann DG; Talmadge JE
Int J Immunopharmacol; 1999 Aug; 21(8):509-21. PubMed ID: 10458540
[TBL] [Abstract][Full Text] [Related]
28. Polymerase chain reaction detection of cells carrying t(14;18) in bone marrow of patients with follicular and diffuse large B-cell lymphoma: the importance of analysis at diagnosis and significance of long-term follow-up.
Papajík T; Jedlicková K; Kriegová E; Jarosová M; Raida L; Faber E; Hubácek J; Vondráková J; Pikalová Z; Indrák K
Neoplasma; 2001; 48(6):501-5. PubMed ID: 11949845
[TBL] [Abstract][Full Text] [Related]
29. [Clinical value of flow cytometry in assessing bone marrow involvement of non-Hodgkin's lymphoma].
Song W; Xie Y; Deng L; Shi Y; Li X; Zheng W; Wang X; Lin N; Tu M; Ying Z; Ping L; Liu W; Zhang C; Ding N; Song Y; Zhu J
Zhonghua Yi Xue Za Zhi; 2014 Oct; 94(38):2996-3000. PubMed ID: 25547702
[TBL] [Abstract][Full Text] [Related]
30. Contribution of flow cytometric immunophenotyping and bone marrow trephine biopsy in the detection of lymphoid bone marrow infiltration in non-Hodgkin's lymphomas.
Mazur G; Hałoń A; Wróbel T; Jeleń M; Kuliczkowski K
Neoplasma; 2004; 51(3):159-63. PubMed ID: 15254666
[TBL] [Abstract][Full Text] [Related]
31. TIA-1 expression in lymphoid neoplasms. Identification of subsets with cytotoxic T lymphocyte or natural killer cell differentiation.
Felgar RE; Macon WR; Kinney MC; Roberts S; Pasha T; Salhany KE
Am J Pathol; 1997 Jun; 150(6):1893-900. PubMed ID: 9176382
[TBL] [Abstract][Full Text] [Related]
32. Polymerase chain reaction-based diagnosis of bone marrow involvement in 170 cases of non-Hodgkin lymphoma.
Kang YH; Park CJ; Seo EJ; Huh J; Kim SB; Kang YK; Chi HS
Cancer; 2002 Jun; 94(12):3073-82. PubMed ID: 12115337
[TBL] [Abstract][Full Text] [Related]
33. [The value of multiparameter flow cytometry in diagnosis of lymphocytic leukemia and bone marrow involvement of non-Hodgkin's lymphoma].
Sun XF; He LR; Feng HL; Yan SL; Xia ZJ; Chen XQ
Ai Zheng; 2003 Nov; 22(11):1232-6. PubMed ID: 14613660
[TBL] [Abstract][Full Text] [Related]
34. Adhesion receptors on peripheral blood leukemic B cells. A comparative study on B cell chronic lymphocytic leukemia and related lymphoma/leukemias.
Csanaky G; Matutes E; Vass JA; Morilla R; Catovsky D
Leukemia; 1997 Mar; 11(3):408-15. PubMed ID: 9067581
[TBL] [Abstract][Full Text] [Related]
35. Use of the JL1 epitope, which encompasses the nonglycosylation site of CD43, as a marker of immature/neoplastic Langerhans cells.
Park HJ; Jeon YK; Lee AH; Oh YH; Park SH; Jung KC
Am J Surg Pathol; 2012 Aug; 36(8):1150-7. PubMed ID: 22790855
[TBL] [Abstract][Full Text] [Related]
36. Aberrant expression of T-cell-associated antigens on B-cell non-Hodgkin lymphomas.
Kaleem Z; White G; Zutter MM
Am J Clin Pathol; 2001 Mar; 115(3):396-403. PubMed ID: 11242796
[TBL] [Abstract][Full Text] [Related]
37. [Clinical and pathological reassessment of 493 cases of non-Hodgkin's lymphomas according to current WHO classification of lymphoid neoplasms].
Xiao C; Su ZL; Wu QL; Gao HY; Fang JC; Xia ZJ; Guan ZZ
Zhonghua Bing Li Xue Za Zhi; 2005 Jan; 34(1):22-7. PubMed ID: 15796877
[TBL] [Abstract][Full Text] [Related]
38. The expression of granulysin in systemic anaplastic large cell lymphoma in childhood.
Kitamura N; Katagiri YU; Itagaki M; Miyagawa Y; Onda K; Okita H; Mori A; Fujimoto J; Kiyokawa N
Leuk Res; 2009 Jul; 33(7):908-12. PubMed ID: 19243819
[TBL] [Abstract][Full Text] [Related]
39. Determination of normal expression patterns of CD86, CD210a, CD261, CD262, CD264, CD358, and CD361 in peripheral blood and bone marrow cells by flow cytometry.
Rudolf-Oliveira RCM; Auat M; Cardoso CC; Santos-Pirath IM; Lange BG; Pires-Silva J; Moraes ACR; Dametto GC; Pirolli MM; Colombo MDHP; Santos-Silva MC
Immunol Lett; 2018 Feb; 194():44-55. PubMed ID: 29274771
[TBL] [Abstract][Full Text] [Related]
40. Clinical and prognostic significance of bone marrow involvement in patients with diffuse aggressive B-cell lymphoma.
Yan Y; Chan WC; Weisenburger DD; Anderson JR; Bast MA; Vose JM; Bierman PJ; Armitage JO
J Clin Oncol; 1995 Jun; 13(6):1336-42. PubMed ID: 7751877
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]